Montisci R, Chen L, Ruscazio M, Colonna P, Cadeddu C, Caiati C, Montisci M, Meloni L, Iliceto S
Department of Cardiovascular and Neurological Sciences, University of Cagliari, Ospedale S Giovanni di Dio, via Ospedale 46, 09124, Cagliari, Italy.
Heart. 2006 Aug;92(8):1113-8. doi: 10.1136/hrt.2005.078246. Epub 2006 Jan 31.
To test whether preserved coronary flow reserve (CFR) two days after reperfused acute myocardial infarction (AMI) is associated with less microvascular dysfunction (" no-reflow" phenomenon) and is predictive of myocardial viability.
24 patients with anterior AMI underwent CFR assessment in the left anterior descending coronary artery (LAD) with transthoracic echocardiography and myocardial contrast echocardiography (MCE) 48 h after primary angioplasty in the LAD (mean 4 (SD 2) and 3 (1) days, respectively). Low-dose dobutamine echocardiography was performed 6 (3) days after AMI and follow-up echocardiography at three months.
No-reflow extent was greater in patients with impaired CFR (< 2.5) than in those with preserved CFR (> 2.5) (55 (35)% v 11 (25)%, p < 0.001). MCE reflow was more common in patients with preserved CFR (8/12) than in those with reduced CFR (1/12, p < 0.05). Wall motion score index in the LAD territory (A-WMSI) was similar at the first echocardiography (2.14 (0.39) v 2.32 (0.47), NS), although it was better in patients with preserved CFR at dobutamine (1.38 (0.45) v 1.97 (0.67), p < 0.05) and follow-up echocardiography (1.36 (0.40) v 1.97 (0.64), p < 0.05). An inverse correlation was found between CFR and A-WMSI at dobutamine and follow-up echocardiography (r = -0.49, p = 0.016 and r = -0.55, p = 0.005) and between MCE and A-WMSI at dobutamine and follow-up echocardiography (r = -0.75, p < 0.001 and r = -0.75, p < 0.001). By multivariate analysis MCE reflow remained the only predictor of recovery at both dobutamine and follow-up echocardiography (odds ratio 1.06, 95% CI 1 to 1.1, p = 0.009).
CFR is inversely correlated with the extent of microvascular dysfunction at MCE two days after reperfused AMI. CFR and MCE reflow early after AMI are correlated with myocardial viability at follow up.
检测再灌注急性心肌梗死(AMI)两天后保留的冠状动脉血流储备(CFR)是否与较少的微血管功能障碍(“无复流”现象)相关,以及是否可预测心肌存活情况。
24例前壁AMI患者在左前降支冠状动脉(LAD)进行了经皮冠状动脉介入治疗后48小时(平均分别为4(标准差2)天和3(1)天),采用经胸超声心动图和心肌对比超声心动图(MCE)评估LAD的CFR。AMI后6(3)天进行小剂量多巴酚丁胺超声心动图检查,并在三个月时进行随访超声心动图检查。
CFR受损(<2.5)的患者无复流范围大于CFR保留(>2.5)的患者(55(35)%对11(25)%,p<0.001)。CFR保留的患者MCE复流更常见(8/12),而CFR降低的患者则较少见(1/12,p<0.05)。LAD区域的壁运动评分指数(A-WMSI)在首次超声心动图检查时相似(2.14(0.39)对2.32(0.47),无显著性差异);尽管在多巴酚丁胺检查时(1.38(0.45)对1.97(0.67),p<0.05)和随访超声心动图检查时(1.36(0.40)对1.97(0.64),p<0.05),CFR保留的患者情况更好。在多巴酚丁胺检查和随访超声心动图检查时,发现CFR与A-WMSI呈负相关(r=-0.49,p=0.016和r=-0.55,p=0.005),MCE与A-WMSI在多巴酚丁胺检查和随访超声心动图检查时也呈负相关(r=-0.75,p<0.001和r=-0.75,p<0.001)。多因素分析显示,MCE复流在多巴酚丁胺检查和随访超声心动图检查时仍然是恢复的唯一预测因素(优势比1.06,95%可信区间1至1.1,p=0.009)。
再灌注AMI两天后,CFR与MCE时微血管功能障碍的程度呈负相关。AMI后早期的CFR和MCE复流与随访时的心肌存活情况相关。